The Mexican pharmaceutical industry estimates a growth of 36% by 2022

The Mexican pharmaceutical industry estimated a 36% growth in drug production by 2022, with around 1.5 billion pieces more than in 2021, amid the persistent Covid-19 pandemic, inflation, and monkeypox.

During the National Congress of Pharmacies, the leaders of the industry in Mexico, the eighth largest producer of medical equipment worldwide and the first in Latin America projected the production of 5.7 billion pieces by the end of the year, higher than the 4.2 billion in 2021.

Rafael Gual Cosío, general director of Canifarma, indicated: “The growth was extraordinary compared to what we had in previous years, that is, we are growing in double digits, something that we did not see in the last decade.”

And he added that the increased demand for generics was mainly due to an increase of up to 60 percent in private consultations during the pandemic, the National Union of Pharmacy Entrepreneurs said.